GLP-1 REceptor Agonists and Real World EvIdeNce

NCT03959865 · clinicaltrials.gov ↗

UNKNOWN

Status

6000

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Long-acting GLP-1RA
DRUG: Short-acting GLP-1RA
DRUG: Human-based GLP-1RA
DRUG: Exendin-based GLP-1RA
DRUG: Fixed ratio BI/GLP-1RA combination
DRUG: Flexible BI/GLP-1RA combination

Sponsor

University of Padova

Collaborators

[object Object]